Back

NOACs today: safety, efficacy, reversibility.

19 March 2018 (12:45 - 12:55)
Organised by:
Congress Presentation Part of: Uninterrupted dabigatran: exploring the impact on AF ablation Catheter Ablation of Arrhythmias EHRA Premium Access EHRA 2018

About the speaker

Photo
Professor Gregory Yh Lip

University of Liverpool, Liverpool (United Kingdom of Great Britain & Northern Ireland)

4 More presentations in this session

Presentation thumbnail
RE-CIRCUIT: answering the interrupted NOAC question.
Professor S. Willems (Hamburg, DE)
Presentation thumbnail
Refining AF ablation: what do RE-CIRCUIT subanalyses show us?
Doctor H. Calkins (Baltimore, US)
Presentation thumbnail
Applying breakthroughs in AF ablation to your clinical practice.
Professor D. Gupta (Liverpool, GB)
Presentation thumbnail
Q&A: addressing AF ablation for your patients.
Professor G. Lip (Liverpool, GB)

Access the full session

Session thumbnail
Uninterrupted dabigatran: exploring the impact on AF ablation

The Event

Event poster

EHRA 2018

19 March 2018 12:45 CET
You may be interested in
thumbnail
Webinar
Are NOACs already outdated? New trends in anticoagulation therapy
12 December 2022
thumbnail
Congress Presentation
Clinical outcomes after reversal of dabigatran in daily practice: real-world use of idarucizumab 2015-2019
28 August 2020
thumbnail
Congress Presentation
Comparative effectiveness and safety of non-VKA oral anticoagulants versus warfarin in non-valvular atrial fibrillation patients with differential treatment duration: an ARISTOPHANES study analysis
2 September 2019
thumbnail
Congress Presentation
Reversal agents to improve safety in patients treated with antiplatelet P2Y12 inhibitors.
26 August 2022

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources